RU95109727A - Method of seasonal vaccine prophylaxis of measles, diphtheria and tetanus on far north - Google Patents

Method of seasonal vaccine prophylaxis of measles, diphtheria and tetanus on far north

Info

Publication number
RU95109727A
RU95109727A RU95109727/14A RU95109727A RU95109727A RU 95109727 A RU95109727 A RU 95109727A RU 95109727/14 A RU95109727/14 A RU 95109727/14A RU 95109727 A RU95109727 A RU 95109727A RU 95109727 A RU95109727 A RU 95109727A
Authority
RU
Russia
Prior art keywords
diphtheria
tetanus
measles
far north
seasonal vaccine
Prior art date
Application number
RU95109727/14A
Other languages
Russian (ru)
Other versions
RU2127120C1 (en
Inventor
И.А. Новицкий
Л.В. Анпилогова
Original Assignee
Красноярский государственный медицинский институт
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Красноярский государственный медицинский институт filed Critical Красноярский государственный медицинский институт
Priority to RU95109727A priority Critical patent/RU2127120C1/en
Publication of RU95109727A publication Critical patent/RU95109727A/en
Application granted granted Critical
Publication of RU2127120C1 publication Critical patent/RU2127120C1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

FIELD: medicine, pediatrics. SUBSTANCE: children of ecdemic population of Far North were immunized with live measles vaccine or adsorbed diphtheria-tetanus anatoxin from May to September only. EFFECT: enhanced effectiveness.

Claims (1)

Способ сезонной вакцинопрофилактики кори, дифтерии и столбняка на Крайнем Севере. Изобретение относится к медицине, а именно к педиатрии и может быть использовано для вакцинации кори, дифтерии и столбняка в определенные сезоны года. Сущность изобретения состоит в том, что детей пришлого населения Крайнего Севера иммунизируют живой коревой вакциной или адсорбированным дифтерийно-столбнячным-м анатоксином только с мая по сентябрь месяц.Method for seasonal vaccination of measles, diphtheria and tetanus in the High North. The invention relates to medicine, namely to pediatrics and can be used for vaccination of measles, diphtheria and tetanus in certain seasons of the year. The essence of the invention lies in the fact that children of the alien population of the Far North are immunized with live measles vaccine or adsorbed diphtheria-tetanus toxoid only from May to September.
RU95109727A 1995-06-13 1995-06-13 Method for ozone vaccine-prophylaxis of diphtheria and rigor nervorum in extreme north conditions RU2127120C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU95109727A RU2127120C1 (en) 1995-06-13 1995-06-13 Method for ozone vaccine-prophylaxis of diphtheria and rigor nervorum in extreme north conditions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU95109727A RU2127120C1 (en) 1995-06-13 1995-06-13 Method for ozone vaccine-prophylaxis of diphtheria and rigor nervorum in extreme north conditions

Publications (2)

Publication Number Publication Date
RU95109727A true RU95109727A (en) 1997-06-10
RU2127120C1 RU2127120C1 (en) 1999-03-10

Family

ID=20168808

Family Applications (1)

Application Number Title Priority Date Filing Date
RU95109727A RU2127120C1 (en) 1995-06-13 1995-06-13 Method for ozone vaccine-prophylaxis of diphtheria and rigor nervorum in extreme north conditions

Country Status (1)

Country Link
RU (1) RU2127120C1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2185852C1 (en) * 2000-11-09 2002-07-27 Научно-исследовательский институт медицинских проблем Севера СО РАМН Method for vaccine prophylaxis of diphtheria and tetanus in the arctic

Also Published As

Publication number Publication date
RU2127120C1 (en) 1999-03-10

Similar Documents

Publication Publication Date Title
UA40597C2 (en) Vaccine composition, method for treatment of mammals, diseased or receptive to the infection, method for treatment of mammals with cancer, method for production of vaccine composition, composition of adjuvants
FR2620941B1 (en) VACCINE CONTAINING TUMOR ADJUVANTS AND ANTIGENS
LV10203A (en) A test-kit of a protein composition for the detection of infections with AIDS
FR2742756B1 (en) STABILIZERS FOR LIVE VACCINES, VACCINES CONTAINING SAME, AND PROCESSES FOR THEIR PREPARATION
ATE108334T1 (en) IMMUNOTHERAPEUTIC PREPARATIONS FOR THE TREATMENT OF AIDS.
CA2022420A1 (en) Escherichia coli vaccine
ATE279940T1 (en) TREATMENT AND PREVENTION OF HELICOBACTER INFECTIONS
PL332540A1 (en) Method of inducing active immunity using a vaccine conjugate
ATE222930T1 (en) ANTIGENIC DRUG FOR TREATMENT OR PREVENTION
ATE515258T1 (en) MUCOSALIC ADMINISTRATION SYSTEM
DE3686158D1 (en) VACCINE AGAINST MASTITIS.
WO1997047271A3 (en) Cellular vaccines and immunotherapeutics and methods for their preparation
EP0090660A3 (en) Neisseria gonorrhoeae vaccine
NO934106L (en) Liposome polysaccharide vaccines
Migliore-Samour et al. Hydrosoluble immunopotentiating substances extracted from Corynebacterium parvum
CA2133108A1 (en) Pasteurella haemolytica type a-1 bacterin-toxoid vaccine
RU2234267C2 (en) Method for vaccine prophylaxis of epidemic parotitis in far north
DK0603386T3 (en) Parenteral immunization against rotavirus
RU2122862C1 (en) Cell-free antistaphylococcus vaccine for treatment of patients with chronic staphylococcus infection
ES2158857T3 (en) STREPTOQUINASE-BASED VACCINES.
ATE385809T1 (en) SAPONIN COMPOSITIONS AND THEIR USE
WO2025179238A3 (en) Coronavirus vaccine
RU2000112250A (en) METHOD OF SEASONAL VACCINE PROPHYLAXIS OF PAROTITIS IN THE EXTREME NORTH
Dong et al. Preparation of various cholera vaccines and comparison of their immuno-effect.
Rethy Experimental-epidemiological studies on the immunological interactions between live and/or killed virus vaccines applied simultaneously with inactivated monovalent or combined vaccines. Survey of human results achieved between 1960-1978.